E-Learning

3 Consumer Stocks in the Doghouse

Consumer discretionary businesses are levered to the highs and lows of economic cycles. This sensitive demand profile can lead to some stock price volatility, but over the past six months, the industry has stayed on track as its 8.1% return was close to the S&P 500’s.

Read more

1 Value Stock to Target This Week and 2 to Avoid

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

Read more

French Stocks Hit Record as Defense Rallies, Political Risk Dims

(Bloomberg) -- France’s equities benchmark hit a record high, catching up with surging European peers, amid a fresh frenzy for defense stocks in the region and as investors continued to trim the country’s political risk discount. Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyRemembering the Landscape Architect Who Embraced the CityNYC Office Buildings See Resurgence as Investors Pile Into BondsHong Kong Joins Global Stadium Race With New $4 Billion Sports

Read more

Musk's embrace of right-wing politics risks turning off car buyers and sinking Tesla's stock

Elon Musk's car company is required each year to report to investors all the bad things that could happen to it, and the latest version lists every imaginable threat from costly lawsuits to out-of-control battery fires to war and another epidemic. Tesla sales plunged 45% in Europe in January, according to research firm Jato Dynamics, even as overall electric vehicle sales rose. Car industry analysts say it's too early to say for sure how much damage Musk is causing to Tesla because so many other factors could explain its current troubles.

Read more

Surgery Partners (NASDAQ:SGRY) Exceeds Q4 Expectations

Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 17.5% year on year to $864.4 million. The company expects the full year’s revenue to be around $3.38 billion, close to analysts’ estimates. Its non-GAAP profit of $0.44 per share was 16.7% above analysts’ consensus estimates.

Read more

Fortrea (NASDAQ:FTRE) Misses Q4 Revenue Estimates, Stock Drops

Clinical research company Fortrea Holdings (NASDAQ:FTRE) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 1.8% year on year to $697 million. The company’s full-year revenue guidance of $2.5 billion at the midpoint came in 8.7% below analysts’ estimates. Its non-GAAP profit of $0.18 per share was 50.7% below analysts’ consensus estimates.

Read more

Indonesia Defers Short-Selling Amid High Stock Volatility

(Bloomberg) -- Indonesia’s financial regulator will defer short-selling of stocks by investors amid heightened volatility in the nation’s equity markets.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyRemembering the Landscape Architect Who Embraced the CityNYC Office Buildings See Resurgence as Investors Pile Into BondsHong Kong Joins Global Stadium Race With New $4 Billion Sports ParkNJ Transit to Deploy Customer-Service Teams After Record DelaysThe nation

Read more

Mainland China Investors’ Sway Over HK Stocks Grows

(Bloomberg) -- Mainland Chinese investors’ support for Hong Kong stocks is growing, helping to ease their valuation discount to onshore peers and indicating the city’s shares may rise further.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyRemembering the Landscape Architect Who Embraced the CityNYC Office Buildings See Resurgence as Investors Pile Into BondsHong Kong Joins Global Stadium Race With New $4 Billion Sports ParkNJ Transit to Deploy Customer-Serv

Read more